Search results for "criteri"

showing 10 items of 807 documents

New delay-dependent stability of Markovian jump neutral stochastic systems with general unknown transition rates

2015

This paper investigates the delay-dependent stability problem for neutral Markovian jump systems with generally unknown transition rates GUTRs. In this neutral GUTR model, each transition rate is completely unknown or only its estimate value is known. Based on the study of expectations of the stochastic cross-terms containing the integral, a new stability criterion is derived in terms of linear matrix inequalities. In the mathematical derivation process, bounding stochastic cross-terms, model transformation and free-weighting matrix are not employed for less conservatism. Finally, an example is provided to demonstrate the effectiveness of the proposed results.

0209 industrial biotechnologygeneral uncertain transition rateStability criterionModel transformationDelay-dependent stability02 engineering and technologyTransition rate matrixStability (probability)neutral-type stochastic systemTheoretical Computer ScienceDelay dependentMatrix (mathematics)Markovian jump020901 industrial engineering & automationControl theoryBounding overwatch0202 electrical engineering electronic engineering information engineeringApplied mathematicsMathematicscomputer.programming_languageDelay-dependent stability; neutral-type stochastic system;Markovian switching; general uncertain transition rate; mean-square exponentially stable; Control and Systems Engineering; Theoretical Computer Science; Computer Science Applications1707 Computer Vision and Pattern RecognitionMarkovian switchingComputer Science Applications1707 Computer Vision and Pattern RecognitionComputer Science ApplicationsControl and Systems Engineeringmean-square exponentially stable020201 artificial intelligence & image processingcomputerInternational Journal of Systems Science
researchProduct

DESDEO: The Modular and Open Source Framework for Interactive Multiobjective Optimization

2021

Interactive multiobjective optimization methods incorporate preferences from a human decision maker in the optimization process iteratively. This allows the decision maker to focus on a subset of solutions, learn about the underlying trade-offs among the conflicting objective functions in the problem and adjust preferences during the solution process. Incorporating preference information allows computing only solutions that are interesting to the decision maker, decreasing computation time significantly. Thus, interactive methods have many strengths making them viable for various applications. However, there is a lack of existing software frameworks to apply and experiment with interactive …

0209 industrial biotechnologylineaarinen optimointiPareto optimizationGeneral Computer Sciencemulti-criteria decision makingComputer sciencepäätöksentekoevoluutiolaskenta02 engineering and technologyData-driven multiobjective optimizationcomputer.software_genrenonlinear optimizationMulti-objective optimizationData modelingopen source softwareavoin lähdekoodi020901 industrial engineering & automationSoftwareoptimointi0202 electrical engineering electronic engineering information engineeringGeneral Materials ScienceUse casecomputer.programming_languageGraphical user interfacepareto-tehokkuusbusiness.industryGeneral Engineeringinteractive methodsModular designPython (programming language)monitavoiteoptimointiTK1-9971Software frameworkdata-driven multiobjective optimizationevolutionary computation020201 artificial intelligence & image processingElectrical engineering. Electronics. Nuclear engineeringbusinessSoftware engineeringcomputerIEEE Access
researchProduct

Ranking corporate sustainability: a flexible multidimensional approach based on linguistic variables

2017

Corporate sustainability implies a compromise between the present environmental, social, and economic needs of a firm's stakeholders and their future needs. Corporate sustainability is therefore a multidimensional concept. Nowadays, several independent rating agencies rate firms in terms of environmental, social, and governance (ESG) criteria. These ratings are usually used by main sustainability indices such as the Dow Jones Sustainability Index, FTSE4 Good, Stoxx Sustainability Index, or Euronext Vigeo Family to select companies to invest in. Only those firms performing better than the average of their sector are selected. However, although providing linguistic ratings about the performan…

021103 operations researchStrategy and ManagementCorporate governance0211 other engineering and technologiesTOPSIS02 engineering and technologyManagement Science and Operations ResearchMultiple-criteria decision analysisLinguisticsComputer Science ApplicationsEnvironmental Sustainability IndexRankingCorporate sustainabilityOrder (exchange)Management of Technology and InnovationSustainability0202 electrical engineering electronic engineering information engineering020201 artificial intelligence & image processingBusinessBusiness and International ManagementInternational Transactions in Operational Research
researchProduct

The ELECTRE I method to support the FMECA

2018

Abstract In traditional Failure Modes, Effects and Criticality Analysis (FMECA), risk priorities of failure modes are determined through the Risk Priority Number (RPN), which is a function of the three risk parameters Occurrence (O), Severity (S), and Detection (D). In the present paper, an alternative approach to RPN is proposed for the criticality assessment of system failure modes. Particularly, the Multi-Criteria Decision Making (MCDM) method ELECTRE I is proposed to select the most critical failure mode in the set of the failure modes charactering a complex system. The method has been applied to a case study previously proposed by Zammori and Gabrielli (2012).

021110 strategic defence & security studies021103 operations researchComputer science0211 other engineering and technologies02 engineering and technologyFunction (mathematics)Multiple-criteria decision analysisReliability engineeringSet (abstract data type)Failure mode effects and criticality analysisSystem failureControl and Systems EngineeringELECTREFailure mode and effects analysisIFAC-PapersOnLine
researchProduct

Safety regulations : implications of the new risk perspectives

2016

Abstract The current safety regulations for industrial activities are to a large extent functionally oriented and risk-based (informed), expressing what to achieve rather than the means and solutions needed. They are founded on a probability-based perspective on risk, with the use of risk assessment, risk acceptance criteria and tolerability limits. In recent years several risk researchers have argued for the adoption of some new types of risk perspectives which highlight uncertainties rather than probabilities in the way risk is defined, the point being to better reflect the knowledge, and lack of knowledge, dimension of risk. The Norwegian Petroleum Safety Authority has recently implement…

021110 strategic defence & security studiesActuarial scienceta214business.industry0211 other engineering and technologiesFood safety risk analysisregulation02 engineering and technologyrisk acceptance criteriaIndustrial and Manufacturing EngineeringIT risk managementrisk perspectivesIT riskIncentiveRisk analysis (engineering)Risk analysis (business)021105 building & constructionta5141risk acceptance a criteriaBusinessDimension (data warehouse)Safety Risk Reliability and QualityRisk assessmentta512Risk managementReliability Engineering and System Safety
researchProduct

Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study

2020

Abstract Background We aim to evaluate serum neurofilament light chain (sNfL), indicating neuroaxonal damage, as a biomarker at diagnosis in a large cohort of early multiple sclerosis (MS) patients. Methods In a multicentre prospective longitudinal observational cohort, patients with newly diagnosed relapsing-remitting MS (RRMS) or clinically isolated syndrome (CIS) were recruited between August 2010 and November 2015 in 22 centers. Clinical parameters, MRI, and sNfL levels (measured by single molecule array) were assessed at baseline and up to four-year follow-up. Findings Of 814 patients, 54.7% (445) were diagnosed with RRMS and 45.3% (369) with CIS when applying 2010 McDonald criteria (R…

0301 basic medicineAdultMalemedicine.medical_specialtyResearch paperClinical Decision-MakingIntermediate Filamentslcsh:Medicine610 Medicine & healthNewly diagnosedGeneral Biochemistry Genetics and Molecular BiologyMultiple sclerosis03 medical and health sciences0302 clinical medicineAtrophyMultiple Sclerosis Relapsing-RemittingNeurofilament ProteinsInternal medicineGermanymedicineHumansLongitudinal StudiesProspective Studiesddc:610610 Medicine & healthNeurofilament light chainlcsh:R5-920Clinically isolated syndromebusiness.industryMultiple sclerosislcsh:RMcDonald criteriaGeneral MedicineBiomarkermedicine.diseasesNfL030104 developmental biology030220 oncology & carcinogenesisCohortDisease ProgressionCommentaryBiomarker (medicine)Femalelcsh:Medicine (General)businessPredictionFunction and Dysfunction of the Nervous SystemBiomarkersCohort study
researchProduct

Abstract CT046: A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA-mutated locally advanced or metastatic solid tumors

2018

Abstract Background: PIK3CA, a gene that encodes the α-isoform of the catalytic subunit of Class I PI3K (PI3Kα), is frequently mutated or amplified in solid tumors. Taselisib is an oral, potent, selective inhibitor of Class I PI3Kα, γ, and δ isoforms with enhanced activity against PIK3CA-mutated cancer models. Preclinical and clinical data demonstrated that single-agent taselisib has activity in multiple PIK3CA-mutated tumor types. Methods: This open-label phase I study (Cohort X of PMT4979g; NCT01296555) enrolled patients (pts) with PIK3CA-mutated tumors who had progressed after, or failed to respond to, at least one prior treatment regimen and were not candidates for regimens known to pro…

0301 basic medicineCervical cancerCancer Researchmedicine.medical_specialtybusiness.industryEndometrial cancerNot Otherwise SpecifiedCancermedicine.diseaseGastroenterologyHead and neck squamous-cell carcinoma03 medical and health sciencesRegimen030104 developmental biologyOncologyTolerabilityResponse Evaluation Criteria in Solid TumorsInternal medicinemedicinebusinessCancer Research
researchProduct

Selection of a Sustainable Functional Pasta Enriched with Opuntia Using ELECTRE III Methodology

2017

In the last decade, the nutritional and health benefits of Opuntia (Opuntia ficus-indica (L.) Mill.) were discussed by academic scientists and private companies. In particular, the introduction of this substance in frequently consumed foods, like, for example, pasta and bakery products, could have a wide diffusion due to its rich composition in polyphenols, vitamins, polyunsaturated fatty acids, and amino acids. The identified natural cactus compounds are responsible for biologically relevant activities including anti-inflammatory, antioxidant, hypoglycemic, antimicrobial, and neuro-protective properties. The aim of this paper is the evaluation of the best combination of Opuntia quantity an…

0301 basic medicineEngineeringOpuntia ficus-indicamedia_common.quotation_subjectOrganolepticGeography Planning and DevelopmentManagement Monitoring Policy and Law03 medical and health sciences0404 agricultural biotechnologyFunctional foodMulti-criteria decision-makingSustainable agricultureSettore ING-IND/17 - Impianti Industriali MeccaniciQuality (business)Food scienceProduct (category theory)ELECTRE<i>Opuntia ficus-indica</i>; functional food; multi-criteria decision-making; ELECTRE IIIELECTRE III; Functional food; Multi-criteria decision-making; Opuntia ficus-indica; Geography; Planning and Development; Renewable Energy; Sustainability and the Environment; Management; Monitoring; Policy and Lawmedia_commonELECTRE III030109 nutrition & dieteticsbusiness.industryRenewable Energy Sustainability and the EnvironmentRecipeFinal productFunctional food04 agricultural and veterinary sciences040401 food scienceBiotechnologybusiness
researchProduct

Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational …

2019

Abstract Background Regorafenib prolonged overall survival (OS) versus placebo in patients with treatment-refractory metastatic colorectal cancer (mCRC) in phase III trials. We conducted an observational study of regorafenib for patients with mCRC in real-world clinical practice. Methods The international, prospective, CORRELATE study recruited patients with mCRC previously treated with approved therapies, for whom the decision to treat with regorafenib was made by the treating physician according to the local health authority approved label. The primary objective was safety, assessed by treatment-emergent adverse events (TEAEs; National Cancer Institute Common Terminology Criteria for Adve…

0301 basic medicineMaleCancer ResearchLung NeoplasmsColorectal cancerPyridinesGTP Phosphohydrolaseschemistry.chemical_compound0302 clinical medicineObservational studyProspective StudiesNeoplasm MetastasisFatiguePeritoneal NeoplasmsRegorafenibAged 80 and overLiver NeoplasmsCommon Terminology Criteria for Adverse EventsMiddle AgedProgression-Free SurvivalOncology030220 oncology & carcinogenesisHypertensionFemaleHand-Foot SyndromeColorectal NeoplasmsAdultProto-Oncogene Proteins B-rafmedicine.medical_specialtyBone NeoplasmsPlaceboProto-Oncogene Proteins p21(ras)03 medical and health sciencesYoung AdultRegorafenibInternal medicinemedicineHumansAdverse effectSurvival analysisAgedAdverse effectsbusiness.industryPhenylurea CompoundsCarcinomaCancerMembrane ProteinsSurvival analysismedicine.disease030104 developmental biologychemistryObservational studyLymph NodesbusinessAdverse effects; Observational study; Regorafenib; Survival analysisEuropean journal of cancer (Oxford, England : 1990)
researchProduct

A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer

2018

Introduction IMAB362 (Zolbetuximab) is a chimeric monoclonal antibody that binds to Claudin-18.2, a target antigen specific to cancer cells. In vitro, IMAB362 mediates cell death through antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity; thus, IMAB362 may serve as a potent, targeted immunotherapeutic agent. Methods This first-in-human phase I study enroled adult patients (N = 15) with advanced gastric or gastro-oesophageal junction cancer into five sequential single dose-escalation cohorts (33, 100, 300, 600, and 1000 mg/m2) following a 3 + 3 design. Safety/tolerability, including determination of maximum tolerated dose and recommended phase II dose, were the pr…

0301 basic medicineMaleCancer Researchmedicine.medical_specialtyTime FactorsEsophageal NeoplasmsMaximum Tolerated Dosemedicine.medical_treatmentMedizinGastroenterologyAntibodies Monoclonal/administration & dosage03 medical and health sciences0302 clinical medicineAntineoplastic Agents ImmunologicalPharmacokineticsAntineoplastic Agents Immunological/administration & dosageStomach NeoplasmsInternal medicineGermanymedicineHumansDrug Dosage CalculationsAdverse effectInfusions IntravenousAgedbusiness.industryCancerAntibodies MonoclonalEsophagogastric Junction/drug effectsImmunotherapyMiddle Agedmedicine.diseaseLatviaddc:030104 developmental biologyTreatment OutcomeOncologyTolerabilityResponse Evaluation Criteria in Solid Tumors030220 oncology & carcinogenesisToxicityDisease ProgressionFemaleStomach Neoplasms/drug therapyEsophagogastric JunctionEsophageal Neoplasms/drug therapybusinessProgressive disease
researchProduct